trial

Pharmacogenomics-Supported Psychotropic Prescribing Trial

NCTId NCT06929533
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 200 (estimated)
Sponsored by University of Manitoba
Primary completion 2028-12-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
200 (estimated)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2025-07-01
Primary completion
2028-12-31
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Pharmacogenetic Testing

Sponsors

University of ManitobaLead Sponsor
University of CalgaryCollaborator
Shared Health ManitobaCollaborator
Winnipeg Regional Health AuthorityCollaborator
Health Sciences Centre, Winnipeg, ManitobaCollaborator

Investigators

1
Abdullah Al Maruf, PhD, M.Pharm., B.PharmPrincipal Investigator

Sites

2 total
Winnipeg, CanadaWinnipeg, Canada

Facts & assertions

4 sourced
Enrollment
200
Phase
NA
Primary Completion Date
2028-12-31
Status
RECRUITING
relationships
The graph out of here
drug
Pharmacogenetic Testing
drug
lead_sponsor
University of Manitoba
company
collaborator
University of Calgary
company
Shared Health Manitoba
company
indication
Bipolar Disorder
indication
Pharmacogenetics
indication
Mental Disorder
indication
investigator
Abdullah Al Maruf, PhD, M.Pharm., B.Pharm
person